Immunologic Research

, Volume 26, Issue 1–3, pp 255–263

CD5, an important regulator of lymphocyte selection and immune tolerance



The CD5 coreceptor is a cysteine-rich scavenger receptor family glycoprotein that is expressed constitutively on all T cells and a subset of B cells (B1a B cells). It is now generally accepted that the biologic role of CD5 is to regulate intracellular strength induced by antigen receptors in both T and B cells. However, at present it is unclear if this coreceptor's effect on antigen receptor signaling is primarily costimulatory or inhibitory since support for both exists. Our studies focus on understanding the physiologic role of CD5 in the context of regulation of antigen receptor activation, B and T cell selection, and generation/maintenance of immune tolerance. In this overview, I discuss studies using experimental models of lymphocyte selection and tolerance showing that CD5 plays a key role in B and T cell selection as well as generation and maintenance of tolerance. I and others, reviewed here, now provide clear evidence that CD5 is a key regulator of immune tolerance and that alterations of its activity can promote development of autoreactivity.

Key Words

Coreceptor CD5 Thymocytes Activation Selection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kishimoto H, Sprent J: Several different cell surface molecules control negative selection of medullary thymocytes. J Exp Med 1999;190:65–73.PubMedCrossRefGoogle Scholar
  2. 2.
    Greenfield EA, Nguyen KA, Kuchroo VK: CD28/B7 costimulation: a review. Crit Rev Immunol 1998;18:389–418.PubMedGoogle Scholar
  3. 3.
    Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripherla tolerance and autoantibody production in B lymphocytes. J Exp Med 1997;186:1923–1931.PubMedCrossRefGoogle Scholar
  4. 4.
    Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carrol MC: Disruption of the Cr2 locus results in reduction of B 1a cells and in impaired B-cell response to T-independent antigen. Immunity 1996;4:251–262.PubMedCrossRefGoogle Scholar
  5. 5.
    Tsubata T: Co-receptors on B lymphocytes. Curr Opin Immunol 1991;11:249–255.CrossRefGoogle Scholar
  6. 6.
    Fearon DT, Carroll MC: Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000;18:393–422.PubMedCrossRefGoogle Scholar
  7. 7.
    Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Müller W, Killeen N, Rajewsky K: A Role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995;269:535–537.PubMedCrossRefGoogle Scholar
  8. 8.
    Hippen KL, Tze LE, Behrens TW: CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883–890.PubMedCrossRefGoogle Scholar
  9. 9.
    Cantor H, Boyse EA: Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclassesisa differentiative process independent of antigen. J Exp Med 1975;141:1376–1389.PubMedCrossRefGoogle Scholar
  10. 10.
    Ledbetter JA, Rouse RV, Micklem HS, Herzenberg LA: T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens: two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med 1980;152:280–295.PubMedCrossRefGoogle Scholar
  11. 11.
    Hayakawa K, Shinton SA, Asano M, Hardy RR: B-1 cell definition. Curr Top Microbiol Immunol 2000;252:15–22.PubMedGoogle Scholar
  12. 12.
    Kearney JF: CD5+ B-cell networks. Curr Opin Immunol 1993; 5:223–226.PubMedCrossRefGoogle Scholar
  13. 13.
    Kipps TJ: Advances in classification and therapy of indolent B-cell malignancies. Semin Oncol 2002; 29:98–104.PubMedCrossRefGoogle Scholar
  14. 14.
    Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE: CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 1998;188:2301–2311.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan D, Smith D, Meyerson H, Pecora N, Lewandowska K: CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation. Proc Natl Acad Sci USA 2001;98:13,850–13,853.Google Scholar
  16. 16.
    Kaplan D, Smith D: Enzymatic amplification staining for flow cytometric analysis of cell surface molecules. Cytometry 2000;40:81–85.PubMedCrossRefGoogle Scholar
  17. 17.
    Raman C, Knight KL: CD5+ B cells predominate in peripheral tissues of rabbit. J Immunol 1992; 149:3858–3864.PubMedGoogle Scholar
  18. 18.
    Koskinen R, Gobel TW, Tregaskes CA, Young JR, Vainio O: The structure of avian CD5 implies a conserved function. J Immunol 1998;160:4943–4950.PubMedGoogle Scholar
  19. 19.
    Vermeer LA, de Boer NK, Bucci C, Bos NA, Kroese FGM, Alberti S: MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells. Eur J Immunol 1994;24:585–592.PubMedCrossRefGoogle Scholar
  20. 20.
    Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG, Jenkins NA, Krieger M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 1990; 87:8810–8814.PubMedCrossRefGoogle Scholar
  21. 21.
    McAlister MS, Brown MH, Willis AC, Rudd PM, Harvey DJ, Aplin R, Shottom DM, Dwek RA, Barclay AN, Driscoll PC: Structural analysis of the CD5 antigen—expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain I. Eur J Biochem 1998;257:131–141.PubMedCrossRefGoogle Scholar
  22. 22.
    Gebe JA, Kiener PA, Ring HZ, Li X, Francke U, Aruffo A: Molecular cloning, mapping to human chromosome 1 q21–q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins. J Biol Chem 1997;272:6151–6158.PubMedCrossRefGoogle Scholar
  23. 23.
    Hohenester E, Sasaki T, Timpl R: Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struct Biol 1999;6:228–232.PubMedCrossRefGoogle Scholar
  24. 24.
    Padilla O, Calvo J, Vila JM, Arman M, Gimferrer I, Places L, Arias MT, Pujana MA, Vives J, Lozano F: Genomic organization of the human CD5 gene. Immunogenetics 2000;51:993–1001.PubMedCrossRefGoogle Scholar
  25. 25.
    Davis RS, Wang YH, Kubagawa H, Cooper MD: Identification of a family of Fe receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 2001; 98:9772–9777.PubMedCrossRefGoogle Scholar
  26. 26.
    Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K: The B cell surface protein CD72/Ly b-2 is the ligand for CD5. Nature. 1991; 351:662–665.PubMedCrossRefGoogle Scholar
  27. 27.
    Biancone L, Bowen MA, Lim A, Aruffo A, Andres G, Stamenkovic I: Identification of a novel inducible cell-surface ligand for CD5 on activated lymphocytes. J Exp Med 1996;184:811–819.PubMedCrossRefGoogle Scholar
  28. 28.
    Bikah G, Lynd FM, Aruffo AA, Ledbetter JA, Bondada S: A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Int Immunol 1998;10:1185–1196.PubMedCrossRefGoogle Scholar
  29. 29.
    Posposil R, Fitts MG, Mage RG: CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J Exp Med 1996;184:1279–1284.CrossRefGoogle Scholar
  30. 30.
    Calvo J, Places L, Padilla O, Vial JM, Vives J, Bowen MA, Lozano F: Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur J Immunol 1999;29:2119–2129.PubMedCrossRefGoogle Scholar
  31. 31.
    Bowen MA, Aruffo AA, Bajorath J: Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions. Proteins 2000;40:420–428.PubMedCrossRefGoogle Scholar
  32. 32.
    Kishimoto H, Surh CD, Sprent J: A role for Fas in negative selection of thymocytes in vivo. J Exp Med 1998;187:1427–1438.PubMedCrossRefGoogle Scholar
  33. 33.
    Von Boehmer H: Developmental biology of T cells In T cell-receptor transgenic mice. Ann Rev Immunol 1990;8:531–556.CrossRefGoogle Scholar
  34. 34.
    Chen X, Matsuura Y, Keamey JF: CD5 transgenic mice. Curr Top Microbiol Immunol 1995;194:209–217.PubMedGoogle Scholar
  35. 35.
    Punt JA, Havran W, Abe R, Sarin A, Singer A: T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J Exp Med 1997;186:1911–1922.PubMedCrossRefGoogle Scholar
  36. 36.
    Azzam HS, De Jarnette JB, Huang K, Emmons R, Park CS, Sommers CL, El-Khoury D, Shores EW, Love PE: Time tuning of TCR signaling by CD5. J Immunol 2001;166:5464–5472.PubMedGoogle Scholar
  37. 37.
    Page DM: Cutting edge: thymic selection and autoreactivity are regulated by multiple coreceptors involved in T cell activation. J Immunol 1999;163:3577–3581.PubMedGoogle Scholar
  38. 38.
    Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S: CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996;274:1906–1909.PubMedCrossRefGoogle Scholar
  39. 39.
    Raman C, Kuo A, Litchfield DW, Kimberly RP: Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5. J Biol Chem 1998;273:19,183–19,189.CrossRefGoogle Scholar
  40. 40.
    Zhou XY, Yashiro-Ohtani Y, Toyo-Oka K, Park CS, Tai XG, Hamaoka T, Fujiwara H: CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage. J Immunol 2000;164:1260–1268.PubMedGoogle Scholar
  41. 41.
    Verwilghen J, Vandenberghe P, Wallays G, de Boer M, Anthony N, Panayi GS, Ceuppens JL: Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. J Immunol 1993;150:835–846.PubMedGoogle Scholar
  42. 42.
    Kroesen BJ, Bakker A, van Lier RA, The HT, de Leij L: B is specific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28. Cancer Res 1995;55:4409–4415.PubMedGoogle Scholar
  43. 43.
    Martin F, Kearney JF: B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001;13:195–201.PubMedCrossRefGoogle Scholar
  44. 44.
    Porakishvili N, Mageed R, Jamin C, Pers JO, Kulikova N, Renaudineau Y, Lydyard PM, Youinou P: Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol 2001;54:30–38.PubMedCrossRefGoogle Scholar
  45. 45.
    Hayakawa K, Carmack CE, Hyman R, Hardy RR: Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J Exp Med 1990;172:869–878.PubMedCrossRefGoogle Scholar
  46. 46.
    Amold LW, Pennell CA, McCray SK, Clarke SH: Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 1994;179:1585–1595.CrossRefGoogle Scholar
  47. 47.
    Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR: Positive selection of natural autoractive B cells. Science 1999;285:113–116.PubMedCrossRefGoogle Scholar
  48. 48.
    Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A: Induction of self-tolerance in mature B lymphocytes. Nature 1989;342:385–391.PubMedCrossRefGoogle Scholar
  49. 49.
    Lozano F, Simarro M, Calvo J, Vila JM, Padilla O, Bowen MA, Campbell KS: CD5 signal transduction: positive ornegative modulation of antigen receptor signaling. Crit Rev Immunol 2000; 20:347–358.PubMedGoogle Scholar
  50. 50.
    Berland R, Wortis HH: Origins and functions of B-1 cells with notes on the role of cd5. Annu Rev Immunol 2002;20:253–300.PubMedCrossRefGoogle Scholar
  51. 51.
    Raman C, Kimberly RP: Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation. Cutting Edge-J Immunol 1998;161.Google Scholar
  52. 52.
    Calvo J, Vilda JM, Places LMSOP, Andreu D, Campbell KS, Aussel C, Lozano F: Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by case in kinase II. J Immunol 1998;161:6022–6029.PubMedGoogle Scholar
  53. 53.
    Lu X, Axtell RC, Collawn JF, Gibson A, Justement LB, Raman C: AP2 adaptorcomplex-dependent internalization of CD5: differential regulation in T and B cells. J Immunol 2002;168:5612–5620.PubMedGoogle Scholar
  54. 54.
    Owen DJ, Evans PR: A structural explanation for the recognition of tyrosine-based endocytotic signals. Science 1998;282:1327–1332.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  1. 1.Division of Clinical Immunology and Rheumatology, Department of MedicineUniversity of Alabama at BirminghamBirmingham

Personalised recommendations